Eli Lilly’s animal-health buy to face 27 May EC phase I deadline (corrects*)
Pharmaceutical company Eli Lilly today notified its intended purchase of a portfolio of animal-health products owned by fellow drug-maker Pfizer to the European Commission for merger-control approval. An initial 27 May...To view the full article, register now.
Already a subscriber? Click here to view full article